Nunnari G - Search Results

1

Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines.

Nunnari G, Argyris E, Fang J, Mehlman KE, Pomerantz RJ, Daniel R. Nunnari G, et al. Virology. 2005 May 10;335(2):177-84. doi: 10.1016/j.virol.2005.02.015. Virology. 2005. PMID: 15840517 Free article.

2

Pathogenesis of HIV-1 infection within bone marrow cells.

Kulkosky J, Bouhamdan M, Geist A, Nunnari G, Phinney DG, Pomerantz RJ. Kulkosky J, et al. Among authors: nunnari g. Leuk Lymphoma. 2000 May;37(5-6):497-515. doi: 10.3109/10428190009058502. Leuk Lymphoma. 2000. PMID: 11042510 Review.

3

Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.

Dornadula G, Nunnari G, Vanella M, Roman J, Babinchak T, DeSimone J, Stern J, Braffman M, Zhang H, Pomerantz RJ. Dornadula G, et al. Among authors: nunnari g. J Infect Dis. 2001 Jun 1;183(11):1682-7. doi: 10.1086/320715. Epub 2001 Apr 27. J Infect Dis. 2001. PMID: 11343220

4

Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections.

Nunnari G, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, Pomerantz RJ. Nunnari G, et al. AIDS. 2002 Jan 4;16(1):39-45. doi: 10.1097/00002030-200201040-00006. AIDS. 2002. PMID: 11741161

5

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.

Kulkosky J, Nunnari G, Otero M, Calarota S, Dornadula G, Zhang H, Malin A, Sullivan J, Xu Y, DeSimone J, Babinchak T, Stern J, Cavert W, Haase A, Pomerantz RJ. Kulkosky J, et al. Among authors: nunnari g. J Infect Dis. 2002 Nov 15;186(10):1403-11. doi: 10.1086/344357. Epub 2002 Oct 29. J Infect Dis. 2002. PMID: 12404155

6

Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile.

Nunnari G, Nigro L, Palermo F, Attanasio M, Berger A, Doerr HW, Pomerantz RJ, Cacopardo B. Nunnari G, et al. Ann Intern Med. 2003 Jul 1;139(1):26-30. doi: 10.7326/0003-4819-139-1-200307010-00009. Ann Intern Med. 2003. PMID: 12834315

7

Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts.

Argyris EG, Acheampong E, Nunnari G, Mukhtar M, Williams KJ, Pomerantz RJ. Argyris EG, et al. Among authors: nunnari g. J Virol. 2003 Nov;77(22):12140-51. doi: 10.1128/jvi.77.22.12140-12151.2003. J Virol. 2003. PMID: 14581551 Free PMC article.

8

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

Otero M, Nunnari G, Leto D, Sullivan J, Wang FX, Frank I, Xu Y, Patel C, Dornadula G, Kulkosky J, Pomerantz RJ. Otero M, et al. Among authors: nunnari g. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1097-103. doi: 10.1089/088922203771881194. AIDS Res Hum Retroviruses. 2003. PMID: 14709246

9

Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels.

Nunnari G, Nigro L, Palermo F, Leto D, Pomerantz RJ, Cacopardo B. Nunnari G, et al. Infection. 2003 Dec;31(6):379-82. doi: 10.1007/s15010-003-4038-9. Infection. 2003. PMID: 14735378

10

HIV and GB virus C--can two viruses be better than one?

Pomerantz RJ, Nunnari G. Pomerantz RJ, et al. Among authors: nunnari g. N Engl J Med. 2004 Mar 4;350(10):963-5. doi: 10.1056/NEJMp048004. N Engl J Med. 2004. PMID: 14999105 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page